Mag. Alexandra Dachenhausen, MAS

Teuschl Y., Bancher C., Dachenhausen A., et al. (2023). Botulinum Toxin-A for the Treatment of Neuropathic Pain after Decompressive Craniotomy in Stroke: Two Cases. Case Rep Neurol, 2023;15: 192–198

Teuschl, Y.; Bancher, C.; Brainin, M.; Dachenhausen, A.; Matz, K.; Pinter MM. (2021). COVID-19-related delays of botulinum toxin injections have a negative impact on the quality of life of patients with dystonia and spasticity: a single-center ambulatory care study. J Neural Transm, Oct 23: 1–5

Matz, K.; Tuomilehto, J.; Teuschl, Y.; Dachenhausen, A.; Brainin, M. (2020). Comparison of oral glucose tolerance test and HbA1c in detection of disorders of glucose metabolism in patients with acute stroke. Cardiovascular Diabetology, 19(1): 204

Matz, K.; Tuomilehto, J.; Teuschl, Y.; Dachenhausen, A.; Brainin, M. (2020). Comparison of oral glucose tolerance test and HbA1c in detection of disorders of glucose metabolism in patients with acute stroke. Cardiovascular Diabetology, 19: https://doi.org/10.1186/s12933-020-01182-6

Teuschl, Y.; Matz, K.; Dachenhausen, A.; Brainin, M. (2020). Impaired glucose metabolism and cognitive performance after mild stroke.

ASPIS Study Group (2018). Multidomain intervention for the prevention of cognitive decline after stroke - a pooled patient-level data analysis. Eur J Neurol., 25: 1182-1188

Teuschl, Y.; Trapl, M:, Ratajczak, P.; Matz, K.; Dachenhausen, A.; Brainin, M. (2018). Systematic dysphagia screening and dietary modifications to reduce stroke-associated pneumonia rates in a stroke-unit. PLoS One, :e0192142: 10.1007/s00415-017-8720-8.

Teuschl, Y.; Matz, K.; Firlinger, B.; Dachenhausen, A.; Tuomilehto, J.; Brainin, M.; ASPIS Study Group. (2017). Preventive effects of multiple domain interventions on lifestyle and risk factor changes in stroke survivors: Evidence from a two-year randomized trial. International Journal of Stroke, 12(9): 976-984

Trapl, M.; Teuschl, Y.; Matz, K.; Dachenhausen, A.; Brainin, M. (2017). Overestimating the risk of aspiration in acute stroke. European Journal of Neurology, 24(6): doi:10.1111/ene.13298

Matz, K.; Seyfang, L.; Dachenhausen, A.; Teuschl, Y.; Tuomilehto, J.; Brainin, M.; for the Austrian Stroke Unit Registry Collaborators (2016). Post-stroke pneumonia at the stroke unit - a registry based analysis of contributing and protective factors. BMC Neurology, 16:107: doi: 10.1186/s12883-016-0627-y

Brainin, M.; Matz, K.; Nemec, M.; Teuschl, Y.; Dachenhausen, A.; Asenbaum-Nan, S.; Bancher, C.; Kepplinger B.; Oberndorfer, S.; Pinter, M.;, Schnider, P.; Tuomilehto, J.; ASPIS StudyGroup (2015). Prevention of poststroke cognitive decline: ASPIS - a multicenter,randomized, observer-blind, parallel group clinical trial to evaluate multiplelifestyle interventions - study design and baseline characteristics. International Journal of Stroke, 10(4): 627-35

Matz K.; Teuschl, Y.; Firlinger, B.; Dachenhausen, A.; Keindl, M.; Seyfang, L.; Tuomilehto, J.; Brainin, M. (2015). Multidomain Lifestyle Interventions for the Prevention of Cognitive Decline After Ischemic Stroke Randomized Trial. Stroke, 46(10): 2874-80

Brainin, M.; Dachenhausen, A. (2013). Psychosocial Distress, an Underinvestigated Risk Factor for Stroke. Stroke, 44(2): 305-306

Teuschl, Y.; Matz, K.; Dachenhausen, A.; Tuomilehto, J.; Brainin, M. (2012). Factors associated with participation in a diabetes prevention program in Austria: a prospective cohort study . Diabetes Management, 2(5): 385-393